Skip to main content
Premium Trial:

Request an Annual Quote

GenomeNext Integrates Genomenon Tech Into Data Analysis Platform

NEW YORK (GenomeWeb) – GenomeNext announced today that it has embedded Genomenon's Mastermind analytic and data visualization tool into its Olympus platform for genomic data analysis.

Launched about a year ago, Mastermind mines millions of medical publications to provide disease-gene-variant relationships curated from primary medical literature, organized into clinical categories, and prioritized by the strength of evidence. GenomeNext said it has now integrated Mastermind search results into Olympus in order to accelerate and automate variant curation required for clinical genomic interpretation.

GenomeNext said it has also signed a reseller agreement with Genomenon to sell the professional version of Mastermind to its Olympus users.

"We're excited to introduce Olympus as the first automated, end-to-end genomic analysis platform that includes a comprehensive genomic search engine for associated medical literature, dramatically reducing the time and costs of variant curation, annotation, and interpretation," GenomeNext CEO James Hirmas said in a statement.

In late 2017, LifeOmic signed a deal with Genomenon to use Mastermind in its genome sequencing data analysis platform.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.